Thyroid cancer is the most common endocrine tumor. Four targeted agents (vandetanib, cabozantinib, sorafenib, and lenvatinib) have attained regulatory approval for advanced thyroid cancer, and several other related agents are now commonly used off-label as first- and second-line treatments for selected patients.
This report aims to provide a comprehensive presentation of the global market for Medicine for the Treatment of Advanced Thyroid Cancer, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Medicine for the Treatment of Advanced Thyroid Cancer. This report contains market size and forecasts of Medicine for the Treatment of Advanced Thyroid Cancer in global, including the following market information:
Global Medicine for the Treatment of Advanced Thyroid Cancer Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Medicine for the Treatment of Advanced Thyroid Cancer Market Sales, 2018-2023, 2024-2029, (Tons)
Global top five Medicine for the Treatment of Advanced Thyroid Cancer companies in 2022 (%)
The global Medicine for the Treatment of Advanced Thyroid Cancer market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Cabozantinib Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Medicine for the Treatment of Advanced Thyroid Cancer include Bayer, AstraZeneca, Sanofi, Exelixis Inc., Ipsen Pharma and Eisai Inc, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Medicine for the Treatment of Advanced Thyroid Cancer manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Medicine for the Treatment of Advanced Thyroid Cancer Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (Tons)
Global Medicine for the Treatment of Advanced Thyroid Cancer Market Segment Percentages, by Type, 2022 (%)
Cabozantinib
Sorafenib
Vandetanib
Lenvatinib
Global Medicine for the Treatment of Advanced Thyroid Cancer Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (Tons)
Global Medicine for the Treatment of Advanced Thyroid Cancer Market Segment Percentages, by Application, 2022 (%)
Combination therapy
Solo Medication
Global Medicine for the Treatment of Advanced Thyroid Cancer Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (Tons)
Global Medicine for the Treatment of Advanced Thyroid Cancer Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Medicine for the Treatment of Advanced Thyroid Cancer revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Medicine for the Treatment of Advanced Thyroid Cancer revenues share in global market, 2022 (%)
Key companies Medicine for the Treatment of Advanced Thyroid Cancer sales in global market, 2018-2023 (Estimated), (Tons)
Key companies Medicine for the Treatment of Advanced Thyroid Cancer sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Bayer
AstraZeneca
Sanofi
Exelixis Inc.
Ipsen Pharma
Eisai Inc
Outline of Major Chapters:
Chapter 1: Introduces the definition of Medicine for the Treatment of Advanced Thyroid Cancer, market overview.
Chapter 2: Global Medicine for the Treatment of Advanced Thyroid Cancer market size in revenue and volume.
Chapter 3: Detailed analysis of Medicine for the Treatment of Advanced Thyroid Cancer manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Medicine for the Treatment of Advanced Thyroid Cancer in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Medicine for the Treatment of Advanced Thyroid Cancer capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Medicine for the Treatment of Advanced Thyroid Cancer Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Medicine for the Treatment of Advanced Thyroid Cancer Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Medicine for the Treatment of Advanced Thyroid Cancer Overall Market Size
2.1 Global Medicine for the Treatment of Advanced Thyroid Cancer Market Size: 2022 VS 2029
2.2 Global Medicine for the Treatment of Advanced Thyroid Cancer Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Medicine for the Treatment of Advanced Thyroid Cancer Sales: 2018-2029
3 Company Landscape
3.1 Top Medicine for the Treatment of Advanced Thyroid Cancer Players in Global Market
3.2 Top Global Medicine for the Treatment of Advanced Thyroid Cancer Companies Ranked by Revenue
3.3 Global Medicine for the Treatment of Advanced Thyroid Cancer Revenue by Companies
3.4 Global Medicine for the Treatment of Advanced Thyroid Cancer Sales by Companies
3.5 Global Medicine for the Treatment of Advanced Thyroid Cancer Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Medicine for the Treatment of Advanced Thyroid Cancer Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Medicine for the Treatment of Advanced Thyroid Cancer Product Type
3.8 Tier 1, Tier 2 and Tier 3 Medicine for the Treatment of Advanced Thyroid Cancer Players in Global Market
3.8.1 List of Global Tier 1 Medicine for the Treatment of Advanced Thyroid Cancer Companies
3.8.2 List of Global Tier 2 and Tier 3 Medicine for the Treatment of Advanced Thyroid Cancer Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Medicine for the Treatment of Advanced Thyroid Cancer Market Size Markets, 2022 & 2029
4.1.2 Cabozantinib
4.1.3 Sorafenib
4.1.4 Vandetanib
4.1.5 Lenvatinib
4.2 By Type - Global Medicine for the Treatment of Advanced Thyroid Cancer Revenue & Forecasts
4.2.1 By Type - Global Medicine for the Treatment of Advanced Thyroid Cancer Revenue, 2018-2023
4.2.2 By Type - Global Medicine for the Treatment of Advanced Thyroid Cancer Revenue, 2024-2029
4.2.3 By Type - Global Medicine for the Treatment of Advanced Thyroid Cancer Revenue Market Share, 2018-2029
4.3 By Type - Global Medicine for the Treatment of Advanced Thyroid Cancer Sales & Forecasts
4.3.1 By Type - Global Medicine for the Treatment of Advanced Thyroid Cancer Sales, 2018-2023
4.3.2 By Type - Global Medicine for the Treatment of Advanced Thyroid Cancer Sales, 2024-2029
4.3.3 By Type - Global Medicine for the Treatment of Advanced Thyroid Cancer Sales Market Share, 2018-2029
4.4 By Type - Global Medicine for the Treatment of Advanced Thyroid Cancer Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Medicine for the Treatment of Advanced Thyroid Cancer Market Size, 2022 & 2029
5.1.2 Combination therapy
5.1.3 Solo Medication
5.2 By Application - Global Medicine for the Treatment of Advanced Thyroid Cancer Revenue & Forecasts
5.2.1 By Application - Global Medicine for the Treatment of Advanced Thyroid Cancer Revenue, 2018-2023
5.2.2 By Application - Global Medicine for the Treatment of Advanced Thyroid Cancer Revenue, 2024-2029
5.2.3 By Application - Global Medicine for the Treatment of Advanced Thyroid Cancer Revenue Market Share, 2018-2029
5.3 By Application - Global Medicine for the Treatment of Advanced Thyroid Cancer Sales & Forecasts
5.3.1 By Application - Global Medicine for the Treatment of Advanced Thyroid Cancer Sales, 2018-2023
5.3.2 By Application - Global Medicine for the Treatment of Advanced Thyroid Cancer Sales, 2024-2029
5.3.3 By Application - Global Medicine for the Treatment of Advanced Thyroid Cancer Sales Market Share, 2018-2029
5.4 By Application - Global Medicine for the Treatment of Advanced Thyroid Cancer Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region - Global Medicine for the Treatment of Advanced Thyroid Cancer Market Size, 2022 & 2029
6.2 By Region - Global Medicine for the Treatment of Advanced Thyroid Cancer Revenue & Forecasts
6.2.1 By Region - Global Medicine for the Treatment of Advanced Thyroid Cancer Revenue, 2018-2023
6.2.2 By Region - Global Medicine for the Treatment of Advanced Thyroid Cancer Revenue, 2024-2029
6.2.3 By Region - Global Medicine for the Treatment of Advanced Thyroid Cancer Revenue Market Share, 2018-2029
6.3 By Region - Global Medicine for the Treatment of Advanced Thyroid Cancer Sales & Forecasts
6.3.1 By Region - Global Medicine for the Treatment of Advanced Thyroid Cancer Sales, 2018-2023
6.3.2 By Region - Global Medicine for the Treatment of Advanced Thyroid Cancer Sales, 2024-2029
6.3.3 By Region - Global Medicine for the Treatment of Advanced Thyroid Cancer Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country - North America Medicine for the Treatment of Advanced Thyroid Cancer Revenue, 2018-2029
6.4.2 By Country - North America Medicine for the Treatment of Advanced Thyroid Cancer Sales, 2018-2029
6.4.3 US Medicine for the Treatment of Advanced Thyroid Cancer Market Size, 2018-2029
6.4.4 Canada Medicine for the Treatment of Advanced Thyroid Cancer Market Size, 2018-2029
6.4.5 Mexico Medicine for the Treatment of Advanced Thyroid Cancer Market Size, 2018-2029
6.5 Europe
6.5.1 By Country - Europe Medicine for the Treatment of Advanced Thyroid Cancer Revenue, 2018-2029
6.5.2 By Country - Europe Medicine for the Treatment of Advanced Thyroid Cancer Sales, 2018-2029
6.5.3 Germany Medicine for the Treatment of Advanced Thyroid Cancer Market Size, 2018-2029
6.5.4 France Medicine for the Treatment of Advanced Thyroid Cancer Market Size, 2018-2029
6.5.5 U.K. Medicine for the Treatment of Advanced Thyroid Cancer Market Size, 2018-2029
6.5.6 Italy Medicine for the Treatment of Advanced Thyroid Cancer Market Size, 2018-2029
6.5.7 Russia Medicine for the Treatment of Advanced Thyroid Cancer Market Size, 2018-2029
6.5.8 Nordic Countries Medicine for the Treatment of Advanced Thyroid Cancer Market Size, 2018-2029
6.5.9 Benelux Medicine for the Treatment of Advanced Thyroid Cancer Market Size, 2018-2029
6.6 Asia
6.6.1 By Region - Asia Medicine for the Treatment of Advanced Thyroid Cancer Revenue, 2018-2029
6.6.2 By Region - Asia Medicine for the Treatment of Advanced Thyroid Cancer Sales, 2018-2029
6.6.3 China Medicine for the Treatment of Advanced Thyroid Cancer Market Size, 2018-2029
6.6.4 Japan Medicine for the Treatment of Advanced Thyroid Cancer Market Size, 2018-2029
6.6.5 South Korea Medicine for the Treatment of Advanced Thyroid Cancer Market Size, 2018-2029
6.6.6 Southeast Asia Medicine for the Treatment of Advanced Thyroid Cancer Market Size, 2018-2029
6.6.7 India Medicine for the Treatment of Advanced Thyroid Cancer Market Size, 2018-2029
6.7 South America
6.7.1 By Country - South America Medicine for the Treatment of Advanced Thyroid Cancer Revenue, 2018-2029
6.7.2 By Country - South America Medicine for the Treatment of Advanced Thyroid Cancer Sales, 2018-2029
6.7.3 Brazil Medicine for the Treatment of Advanced Thyroid Cancer Market Size, 2018-2029
6.7.4 Argentina Medicine for the Treatment of Advanced Thyroid Cancer Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Medicine for the Treatment of Advanced Thyroid Cancer Revenue, 2018-2029
6.8.2 By Country - Middle East & Africa Medicine for the Treatment of Advanced Thyroid Cancer Sales, 2018-2029
6.8.3 Turkey Medicine for the Treatment of Advanced Thyroid Cancer Market Size, 2018-2029
6.8.4 Israel Medicine for the Treatment of Advanced Thyroid Cancer Market Size, 2018-2029
6.8.5 Saudi Arabia Medicine for the Treatment of Advanced Thyroid Cancer Market Size, 2018-2029
6.8.6 UAE Medicine for the Treatment of Advanced Thyroid Cancer Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Bayer
7.1.1 Bayer Company Summary
7.1.2 Bayer Business Overview
7.1.3 Bayer Medicine for the Treatment of Advanced Thyroid Cancer Major Product Offerings
7.1.4 Bayer Medicine for the Treatment of Advanced Thyroid Cancer Sales and Revenue in Global (2018-2023)
7.1.5 Bayer Key News & Latest Developments
7.2 AstraZeneca
7.2.1 AstraZeneca Company Summary
7.2.2 AstraZeneca Business Overview
7.2.3 AstraZeneca Medicine for the Treatment of Advanced Thyroid Cancer Major Product Offerings
7.2.4 AstraZeneca Medicine for the Treatment of Advanced Thyroid Cancer Sales and Revenue in Global (2018-2023)
7.2.5 AstraZeneca Key News & Latest Developments
7.3 Sanofi
7.3.1 Sanofi Company Summary
7.3.2 Sanofi Business Overview
7.3.3 Sanofi Medicine for the Treatment of Advanced Thyroid Cancer Major Product Offerings
7.3.4 Sanofi Medicine for the Treatment of Advanced Thyroid Cancer Sales and Revenue in Global (2018-2023)
7.3.5 Sanofi Key News & Latest Developments
7.4 Exelixis Inc.
7.4.1 Exelixis Inc. Company Summary
7.4.2 Exelixis Inc. Business Overview
7.4.3 Exelixis Inc. Medicine for the Treatment of Advanced Thyroid Cancer Major Product Offerings
7.4.4 Exelixis Inc. Medicine for the Treatment of Advanced Thyroid Cancer Sales and Revenue in Global (2018-2023)
7.4.5 Exelixis Inc. Key News & Latest Developments
7.5 Ipsen Pharma
7.5.1 Ipsen Pharma Company Summary
7.5.2 Ipsen Pharma Business Overview
7.5.3 Ipsen Pharma Medicine for the Treatment of Advanced Thyroid Cancer Major Product Offerings
7.5.4 Ipsen Pharma Medicine for the Treatment of Advanced Thyroid Cancer Sales and Revenue in Global (2018-2023)
7.5.5 Ipsen Pharma Key News & Latest Developments
7.6 Eisai Inc
7.6.1 Eisai Inc Company Summary
7.6.2 Eisai Inc Business Overview
7.6.3 Eisai Inc Medicine for the Treatment of Advanced Thyroid Cancer Major Product Offerings
7.6.4 Eisai Inc Medicine for the Treatment of Advanced Thyroid Cancer Sales and Revenue in Global (2018-2023)
7.6.5 Eisai Inc Key News & Latest Developments
8 Global Medicine for the Treatment of Advanced Thyroid Cancer Production Capacity, Analysis
8.1 Global Medicine for the Treatment of Advanced Thyroid Cancer Production Capacity, 2018-2029
8.2 Medicine for the Treatment of Advanced Thyroid Cancer Production Capacity of Key Manufacturers in Global Market
8.3 Global Medicine for the Treatment of Advanced Thyroid Cancer Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Medicine for the Treatment of Advanced Thyroid Cancer Supply Chain Analysis
10.1 Medicine for the Treatment of Advanced Thyroid Cancer Industry Value Chain
10.2 Medicine for the Treatment of Advanced Thyroid Cancer Upstream Market
10.3 Medicine for the Treatment of Advanced Thyroid Cancer Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Medicine for the Treatment of Advanced Thyroid Cancer Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Key Players of Medicine for the Treatment of Advanced Thyroid Cancer in Global Market
Table 2. Top Medicine for the Treatment of Advanced Thyroid Cancer Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Medicine for the Treatment of Advanced Thyroid Cancer Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Medicine for the Treatment of Advanced Thyroid Cancer Revenue Share by Companies, 2018-2023
Table 5. Global Medicine for the Treatment of Advanced Thyroid Cancer Sales by Companies, (Tons), 2018-2023
Table 6. Global Medicine for the Treatment of Advanced Thyroid Cancer Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Medicine for the Treatment of Advanced Thyroid Cancer Price (2018-2023) & (US$/Kg)
Table 8. Global Manufacturers Medicine for the Treatment of Advanced Thyroid Cancer Product Type
Table 9. List of Global Tier 1 Medicine for the Treatment of Advanced Thyroid Cancer Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Medicine for the Treatment of Advanced Thyroid Cancer Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Medicine for the Treatment of Advanced Thyroid Cancer Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global Medicine for the Treatment of Advanced Thyroid Cancer Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Medicine for the Treatment of Advanced Thyroid Cancer Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global Medicine for the Treatment of Advanced Thyroid Cancer Sales (Tons), 2018-2023
Table 15. By Type - Global Medicine for the Treatment of Advanced Thyroid Cancer Sales (Tons), 2024-2029
Table 16. By Application ? Global Medicine for the Treatment of Advanced Thyroid Cancer Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global Medicine for the Treatment of Advanced Thyroid Cancer Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Medicine for the Treatment of Advanced Thyroid Cancer Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global Medicine for the Treatment of Advanced Thyroid Cancer Sales (Tons), 2018-2023
Table 20. By Application - Global Medicine for the Treatment of Advanced Thyroid Cancer Sales (Tons), 2024-2029
Table 21. By Region ? Global Medicine for the Treatment of Advanced Thyroid Cancer Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global Medicine for the Treatment of Advanced Thyroid Cancer Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Medicine for the Treatment of Advanced Thyroid Cancer Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global Medicine for the Treatment of Advanced Thyroid Cancer Sales (Tons), 2018-2023
Table 25. By Region - Global Medicine for the Treatment of Advanced Thyroid Cancer Sales (Tons), 2024-2029
Table 26. By Country - North America Medicine for the Treatment of Advanced Thyroid Cancer Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Medicine for the Treatment of Advanced Thyroid Cancer Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America Medicine for the Treatment of Advanced Thyroid Cancer Sales, (Tons), 2018-2023
Table 29. By Country - North America Medicine for the Treatment of Advanced Thyroid Cancer Sales, (Tons), 2024-2029
Table 30. By Country - Europe Medicine for the Treatment of Advanced Thyroid Cancer Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Medicine for the Treatment of Advanced Thyroid Cancer Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe Medicine for the Treatment of Advanced Thyroid Cancer Sales, (Tons), 2018-2023
Table 33. By Country - Europe Medicine for the Treatment of Advanced Thyroid Cancer Sales, (Tons), 2024-2029
Table 34. By Region - Asia Medicine for the Treatment of Advanced Thyroid Cancer Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Medicine for the Treatment of Advanced Thyroid Cancer Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia Medicine for the Treatment of Advanced Thyroid Cancer Sales, (Tons), 2018-2023
Table 37. By Region - Asia Medicine for the Treatment of Advanced Thyroid Cancer Sales, (Tons), 2024-2029
Table 38. By Country - South America Medicine for the Treatment of Advanced Thyroid Cancer Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Medicine for the Treatment of Advanced Thyroid Cancer Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America Medicine for the Treatment of Advanced Thyroid Cancer Sales, (Tons), 2018-2023
Table 41. By Country - South America Medicine for the Treatment of Advanced Thyroid Cancer Sales, (Tons), 2024-2029
Table 42. By Country - Middle East & Africa Medicine for the Treatment of Advanced Thyroid Cancer Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Medicine for the Treatment of Advanced Thyroid Cancer Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa Medicine for the Treatment of Advanced Thyroid Cancer Sales, (Tons), 2018-2023
Table 45. By Country - Middle East & Africa Medicine for the Treatment of Advanced Thyroid Cancer Sales, (Tons), 2024-2029
Table 46. Bayer Company Summary
Table 47. Bayer Medicine for the Treatment of Advanced Thyroid Cancer Product Offerings
Table 48. Bayer Medicine for the Treatment of Advanced Thyroid Cancer Sales (Tons), Revenue (US$, Mn) and Average Price (US$/Kg) (2018-2023)
Table 49. Bayer Key News & Latest Developments
Table 50. AstraZeneca Company Summary
Table 51. AstraZeneca Medicine for the Treatment of Advanced Thyroid Cancer Product Offerings
Table 52. AstraZeneca Medicine for the Treatment of Advanced Thyroid Cancer Sales (Tons), Revenue (US$, Mn) and Average Price (US$/Kg) (2018-2023)
Table 53. AstraZeneca Key News & Latest Developments
Table 54. Sanofi Company Summary
Table 55. Sanofi Medicine for the Treatment of Advanced Thyroid Cancer Product Offerings
Table 56. Sanofi Medicine for the Treatment of Advanced Thyroid Cancer Sales (Tons), Revenue (US$, Mn) and Average Price (US$/Kg) (2018-2023)
Table 57. Sanofi Key News & Latest Developments
Table 58. Exelixis Inc. Company Summary
Table 59. Exelixis Inc. Medicine for the Treatment of Advanced Thyroid Cancer Product Offerings
Table 60. Exelixis Inc. Medicine for the Treatment of Advanced Thyroid Cancer Sales (Tons), Revenue (US$, Mn) and Average Price (US$/Kg) (2018-2023)
Table 61. Exelixis Inc. Key News & Latest Developments
Table 62. Ipsen Pharma Company Summary
Table 63. Ipsen Pharma Medicine for the Treatment of Advanced Thyroid Cancer Product Offerings
Table 64. Ipsen Pharma Medicine for the Treatment of Advanced Thyroid Cancer Sales (Tons), Revenue (US$, Mn) and Average Price (US$/Kg) (2018-2023)
Table 65. Ipsen Pharma Key News & Latest Developments
Table 66. Eisai Inc Company Summary
Table 67. Eisai Inc Medicine for the Treatment of Advanced Thyroid Cancer Product Offerings
Table 68. Eisai Inc Medicine for the Treatment of Advanced Thyroid Cancer Sales (Tons), Revenue (US$, Mn) and Average Price (US$/Kg) (2018-2023)
Table 69. Eisai Inc Key News & Latest Developments
Table 70. Medicine for the Treatment of Advanced Thyroid Cancer Production Capacity (Tons) of Key Manufacturers in Global Market, 2021-2023 (Tons)
Table 71. Global Medicine for the Treatment of Advanced Thyroid Cancer Capacity Market Share of Key Manufacturers, 2021-2023
Table 72. Global Medicine for the Treatment of Advanced Thyroid Cancer Production by Region, 2018-2023 (Tons)
Table 73. Global Medicine for the Treatment of Advanced Thyroid Cancer Production by Region, 2024-2029 (Tons)
Table 74. Medicine for the Treatment of Advanced Thyroid Cancer Market Opportunities & Trends in Global Market
Table 75. Medicine for the Treatment of Advanced Thyroid Cancer Market Drivers in Global Market
Table 76. Medicine for the Treatment of Advanced Thyroid Cancer Market Restraints in Global Market
Table 77. Medicine for the Treatment of Advanced Thyroid Cancer Raw Materials
Table 78. Medicine for the Treatment of Advanced Thyroid Cancer Raw Materials Suppliers in Global Market
Table 79. Typical Medicine for the Treatment of Advanced Thyroid Cancer Downstream
Table 80. Medicine for the Treatment of Advanced Thyroid Cancer Downstream Clients in Global Market
Table 81. Medicine for the Treatment of Advanced Thyroid Cancer Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Medicine for the Treatment of Advanced Thyroid Cancer Segment by Type in 2022
Figure 2. Medicine for the Treatment of Advanced Thyroid Cancer Segment by Application in 2022
Figure 3. Global Medicine for the Treatment of Advanced Thyroid Cancer Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Medicine for the Treatment of Advanced Thyroid Cancer Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Medicine for the Treatment of Advanced Thyroid Cancer Revenue, 2018-2029 (US$, Mn)
Figure 7. Medicine for the Treatment of Advanced Thyroid Cancer Sales in Global Market: 2018-2029 (Tons)
Figure 8. The Top 3 and 5 Players Market Share by Medicine for the Treatment of Advanced Thyroid Cancer Revenue in 2022
Figure 9. By Type - Global Medicine for the Treatment of Advanced Thyroid Cancer Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global Medicine for the Treatment of Advanced Thyroid Cancer Revenue Market Share, 2018-2029
Figure 11. By Type - Global Medicine for the Treatment of Advanced Thyroid Cancer Sales Market Share, 2018-2029
Figure 12. By Type - Global Medicine for the Treatment of Advanced Thyroid Cancer Price (US$/Kg), 2018-2029
Figure 13. By Application - Global Medicine for the Treatment of Advanced Thyroid Cancer Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global Medicine for the Treatment of Advanced Thyroid Cancer Revenue Market Share, 2018-2029
Figure 15. By Application - Global Medicine for the Treatment of Advanced Thyroid Cancer Sales Market Share, 2018-2029
Figure 16. By Application - Global Medicine for the Treatment of Advanced Thyroid Cancer Price (US$/Kg), 2018-2029
Figure 17. By Region - Global Medicine for the Treatment of Advanced Thyroid Cancer Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global Medicine for the Treatment of Advanced Thyroid Cancer Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global Medicine for the Treatment of Advanced Thyroid Cancer Revenue Market Share, 2018-2029
Figure 20. By Region - Global Medicine for the Treatment of Advanced Thyroid Cancer Sales Market Share, 2018-2029
Figure 21. By Country - North America Medicine for the Treatment of Advanced Thyroid Cancer Revenue Market Share, 2018-2029
Figure 22. By Country - North America Medicine for the Treatment of Advanced Thyroid Cancer Sales Market Share, 2018-2029
Figure 23. US Medicine for the Treatment of Advanced Thyroid Cancer Revenue, (US$, Mn), 2018-2029
Figure 24. Canada Medicine for the Treatment of Advanced Thyroid Cancer Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico Medicine for the Treatment of Advanced Thyroid Cancer Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe Medicine for the Treatment of Advanced Thyroid Cancer Revenue Market Share, 2018-2029
Figure 27. By Country - Europe Medicine for the Treatment of Advanced Thyroid Cancer Sales Market Share, 2018-2029
Figure 28. Germany Medicine for the Treatment of Advanced Thyroid Cancer Revenue, (US$, Mn), 2018-2029
Figure 29. France Medicine for the Treatment of Advanced Thyroid Cancer Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. Medicine for the Treatment of Advanced Thyroid Cancer Revenue, (US$, Mn), 2018-2029
Figure 31. Italy Medicine for the Treatment of Advanced Thyroid Cancer Revenue, (US$, Mn), 2018-2029
Figure 32. Russia Medicine for the Treatment of Advanced Thyroid Cancer Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries Medicine for the Treatment of Advanced Thyroid Cancer Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux Medicine for the Treatment of Advanced Thyroid Cancer Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia Medicine for the Treatment of Advanced Thyroid Cancer Revenue Market Share, 2018-2029
Figure 36. By Region - Asia Medicine for the Treatment of Advanced Thyroid Cancer Sales Market Share, 2018-2029
Figure 37. China Medicine for the Treatment of Advanced Thyroid Cancer Revenue, (US$, Mn), 2018-2029
Figure 38. Japan Medicine for the Treatment of Advanced Thyroid Cancer Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea Medicine for the Treatment of Advanced Thyroid Cancer Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia Medicine for the Treatment of Advanced Thyroid Cancer Revenue, (US$, Mn), 2018-2029
Figure 41. India Medicine for the Treatment of Advanced Thyroid Cancer Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America Medicine for the Treatment of Advanced Thyroid Cancer Revenue Market Share, 2018-2029
Figure 43. By Country - South America Medicine for the Treatment of Advanced Thyroid Cancer Sales Market Share, 2018-2029
Figure 44. Brazil Medicine for the Treatment of Advanced Thyroid Cancer Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina Medicine for the Treatment of Advanced Thyroid Cancer Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa Medicine for the Treatment of Advanced Thyroid Cancer Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa Medicine for the Treatment of Advanced Thyroid Cancer Sales Market Share, 2018-2029
Figure 48. Turkey Medicine for the Treatment of Advanced Thyroid Cancer Revenue, (US$, Mn), 2018-2029
Figure 49. Israel Medicine for the Treatment of Advanced Thyroid Cancer Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia Medicine for the Treatment of Advanced Thyroid Cancer Revenue, (US$, Mn), 2018-2029
Figure 51. UAE Medicine for the Treatment of Advanced Thyroid Cancer Revenue, (US$, Mn), 2018-2029
Figure 52. Global Medicine for the Treatment of Advanced Thyroid Cancer Production Capacity (Tons), 2018-2029
Figure 53. The Percentage of Production Medicine for the Treatment of Advanced Thyroid Cancer by Region, 2022 VS 2029
Figure 54. Medicine for the Treatment of Advanced Thyroid Cancer Industry Value Chain
Figure 55. Marketing Channels
